18-57655336-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001374385.1(ATP8B1):​c.2789G>A​(p.Arg930Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000856 in 1,614,152 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R930R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0042 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 5 hom. )

Consequence

ATP8B1
NM_001374385.1 missense

Scores

3
6
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.16

Publications

8 publications found
Variant links:
Genes affected
ATP8B1 (HGNC:3706): (ATPase phospholipid transporting 8B1) This gene encodes a member of the P-type cation transport ATPase family, which belongs to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. [provided by RefSeq, Jul 2008]
ATP8B1-AS1 (HGNC:56042): (ATP8B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013903439).
BP6
Variant 18-57655336-C-T is Benign according to our data. Variant chr18-57655336-C-T is described in ClinVar as Benign. ClinVar VariationId is 259819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00422 (642/152278) while in subpopulation AFR AF = 0.0141 (587/41558). AF 95% confidence interval is 0.0132. There are 3 homozygotes in GnomAd4. There are 301 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374385.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8B1
NM_001374385.1
MANE Select
c.2789G>Ap.Arg930Gln
missense
Exon 23 of 28NP_001361314.1
ATP8B1
NM_005603.6
c.2789G>Ap.Arg930Gln
missense
Exon 23 of 28NP_005594.2
ATP8B1
NM_001374386.1
c.2639G>Ap.Arg880Gln
missense
Exon 22 of 27NP_001361315.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8B1
ENST00000648908.2
MANE Select
c.2789G>Ap.Arg930Gln
missense
Exon 23 of 28ENSP00000497896.1
ATP8B1-AS1
ENST00000592201.2
TSL:1
n.723-12670C>T
intron
N/A
ATP8B1
ENST00000642462.1
n.*21G>A
non_coding_transcript_exon
Exon 24 of 29ENSP00000494712.1

Frequencies

GnomAD3 genomes
AF:
0.00423
AC:
643
AN:
152160
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00139
AC:
349
AN:
251480
AF XY:
0.00113
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.000506
AC:
739
AN:
1461874
Hom.:
5
Cov.:
32
AF XY:
0.000441
AC XY:
321
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0134
AC:
448
AN:
33480
American (AMR)
AF:
0.00248
AC:
111
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39698
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000665
AC:
74
AN:
1112000
Other (OTH)
AF:
0.00124
AC:
75
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00422
AC:
642
AN:
152278
Hom.:
3
Cov.:
32
AF XY:
0.00404
AC XY:
301
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0141
AC:
587
AN:
41558
American (AMR)
AF:
0.00262
AC:
40
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68022
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
36
72
108
144
180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00167
Hom.:
4
Bravo
AF:
0.00500
ESP6500AA
AF:
0.0120
AC:
53
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00156
AC:
189
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Progressive familial intrahepatic cholestasis type 1 Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.21
T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.014
T
MetaSVM
Uncertain
0.44
D
MutationAssessor
Pathogenic
3.1
M
PhyloP100
6.2
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-2.2
N
REVEL
Uncertain
0.53
Sift
Benign
0.071
T
Sift4G
Benign
0.080
T
Polyphen
1.0
D
Vest4
0.62
MVP
0.93
ClinPred
0.042
T
GERP RS
5.2
Varity_R
0.43
gMVP
0.72
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35623014; hg19: chr18-55322568; COSMIC: COSV105111043; API